CLINICAL_TRIALS
trial_result
· 2014-04-24
Clinical Trial Update: Chemotherapy Followed by Zevalin for Relapsed Mantle Cell Lymphoma [Phase 2]
Summary
A Phase II trial evaluating chemotherapy followed by Zevalin (ibritumomab tiuxetan) for relapsed mantle cell lymphoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED